-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
China News Service, Guangzhou, July 18 (Cai Minjie and He Yuhang) The current cervical cancer vaccines include domestically produced two-valent, imported two-valent, four-valent, and nine-valent vaccines
Human papillomavirus is abbreviated as HPV, which is the main cause of cervical cancer
In 2018, the World Health Organization called for the global elimination of cervical cancer.
Cervical cancer is preventable and controllable and requires early vaccination and early protection
Studies have shown that more than 84.
In December 2019, the National Medical Products Administration approved Xiamen Wantai Biotech's bivalent human papillomavirus vaccine to be marketed
Wang Ming said that cervical cancer is currently the only malignant tumor with a clear etiology, preventable and controllable.